Pfizer can capitalize on drug withdrawal
499909
Pfizer Inc., the world&#39;s biggest drugmaker, may benefit from Merck &amp; Co.&#39;s withdrawal of Vioxx because Pfizer&#39;s competing pain medicine Celebrex hasn&#39;t been linked to increased risk of heart attacks and strokes.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
620499
Sales of its lead drug should expand in 2008.
12098
Cleveland Clinic cardiologist Eric Topol was one of the first to point out the potential heart risk of Merck&#39;s (nyse: MRK - news - people ) withdrawn Vioxx and Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
174409
The company's lead drug will enter phase 1 trials, bringing potential good fortune to investors.
167282
The discontinuation of Exubera, an inhaled insulin, is another black eye for Pfizer, the worldâs biggest drug company, which has recently sustained a series of reversals.
738382
The drug maker is poised to speed past its rivals.
111721
Pfizer Inc. PFE.N , the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose, helped by strong sales of cholesterol treatment Lipitor  and arthritis drug Celebrex.
190069
The FDA issues a health advisory for a top Pfizer drug.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
378410
Large drug companies may have to swallow some bitter medicine, but that could be healthy for shareholders.
511170
Now might be a great time to load up on cutting-edge drugmakers.
407477
By Alejandro Bodipo-Memba, Detroit Free Press  Sep. 7--Pfizer Inc. will donate lab equipment valued at more than $1 million to Michigan-based start-up companies focused on life-science research.
259812
The pharmaceutical enlists help to thwart a troublesome illness.
485764
With the sudden failure of torcetrapib, Pfizer Inc.'s most important experimental product, financial analysts predict shares of the world's largest drugmaker could fall from 5 to 25 percent on Monday and that Pfizer will need to buy other products to fill the void.
15542
Pfizer says not to worry, its arthritis pain drug Celebrex won&#39;t go the way of Vioxx. Pfizer says it won&#39;t withdraw Celebrex, its blockbuster arthritis pain medicine, despite Friday&#39;s disclosure
421539
This morning, Pfizer (nyse: PFE - news - people ) announced that it had received data from two long-term studies in using its arthritis drug Celebrex to prevent cancer.